Just need help with cash flows from operating activities!
Solution
Livers Inc | ||
Statement of Cash Flows | ||
Cash flows from operating activities: | ||
Cash received from customers | $ 2,950,000 | |
Cash payments for merchandise | -$ 1,380,000 | |
Cash paid for operating expenses | -$ 955,000 | |
Cash payment for income tax expense | -$ 125,000 | |
Net cash flow from operating activities | $ 490,000 |
Only cash flow from operating activities is provided as asked.
Cash received from customers | |
Sales revenue | $ 3,000,000 |
Less: Increase in accounts receivable | -$ 50,000 |
Cash received from customers | $ 2,950,000 |
.
Cash payments for merchandise | |
Cost of goods sold | $ 1,400,000 |
Add: Increase in Inventory | $ 20,000 |
Net purchases | $ 1,420,000 |
Less: Increase in Accounts payable | -$ 40,000 |
Cash payments for merchandise | $ 1,380,000 |
.
Cash payments for Operating expenses | |
Operating expenses excluding depreciation | $ 950,000 |
Add: Decrease in accrued expense | $ 5,000 |
Cash payments for Operating expenses | $ 955,000 |
Just need help with cash flows from operating activities! The comparative balance sheet of Livers Inc....
Statement of cash flows-direct method applied to PR 13-1A Instructions Labels and Amount Descriptions Statement of Cash Flows Instructions Dec. 31, 2043 Dec. 31,2072 Assets Cash $155,000.00 $150,000.00 Accounts receivable (net) 450,000.00 400,000.00 Inventories 770,000.00 750,000.00 100,000.00 Investments 0.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 9 Accumulated depreciation equipment (600,000.00) $2,675,000.00 1,200,000.00 (500,000.00) $2,100,000.00 10 Total assets Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 Accrued expenses payable (operating expenses) 50,000.00 45,000.00 30,000.00 14 Dividends payable...
Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows: A. The investments were sold for $175,000 cash. B. Equipment and land were acquired for cash. C. There were no disposals of equipment during the year. D. The common stock was issued for cash. E. There was a $500,000 credit to Retained Earnings for net income. F. There was a $90,000 debit to Retained Earnings for cash dividends declared. Prepare a statement of...
help please! Statement of cash flows-direct method applied to PR 13-1A Instructions Labels and Amount Descriptions Statement of Cash Flows Instructions Dec. 31, 2043 Dec. 31,2072 Assets Cash $155,000.00 $150,000.00 Accounts receivable (net) 450,000.00 400,000.00 Inventories 770,000.00 750,000.00 100,000.00 Investments 0.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 9 Accumulated depreciation equipment (600,000.00) $2,675,000.00 1,200,000.00 (500,000.00) $2,100,000.00 10 Total assets Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 Accrued expenses payable (operating expenses) 50,000.00 45,000.00 30,000.00 14...
4 Show Me How alculator eBook Statement of cash flows-indirect method Statement of Cash Flows Labels and Amount Descriptlons Instructions Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, Is shown as follows: Dec. 31, 20Y2 Dec. 31, 20Y3 Assets $150,000.00 $155,000.00 3 Cash 4Accounts receivable (net) 400,000.00 450,000.00 750,000.00 5 Inventories 770,000.00 6 Investments 100,000.00 0.00 7 Land 500,0000 0.00 Equipment 1,400,000.00 1,200,000.00 9Accumulated depreciation-equipment (600,000.00) (500,000.00) $2,675,000.00 $2,100,000.00 Total assets 10 Liabilities and...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $253,630 $237,840 Accounts receivable (net) 91,880 85,420 Inventories 259,370 252,910 Investments 0 97,980 Land 133,030 0 Equipment 286,170 223,600 Accumulated depreciation—equipment (67,000) (60,300) Total assets $957,080 $837,450 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $173,230 $164,980 Accrued expenses payable (operating expenses) 17,230 21,770 Dividends payable 9,570 7,540 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $261,120 $243,460 Accounts receivable (net) 94,590 87,440 Inventories 267,040 258,890 Investments 0 100,300 Land 136,970 0 Equipment 294,620 228,890 Accumulated depreciation—equipment (68,980) (61,720) Total assets $985,360 $857,260 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $178,350 $168,880 Accrued expenses payable (operating expenses) 17,740 22,290 Dividends payable 9,850 7,720 Common stock,...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $261,120 $243,460 Accounts receivable (net) 94,590 87,440 Inventories 267,040 258,890 Investments 0 100,300 Land 136,970 0 Equipment 294,620 228,890 Accumulated depreciation—equipment (68,980) (61,720) Total assets $985,360 $857,260 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $178,350 $168,880 Accrued expenses payable (operating expenses) 17,740 22,290 Dividends payable 9,850 7,720 Common stock,...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is as follows: Dec. 31, 20Y2 Dec. 31, 20Y3 Assets 2 $625,650.00 $586,340.00 3 Cash Accounts receivable (net) 208,030.00 228,170.00 4 5 Inventories 641,480.00 617,130.00 0.00 240,290.00 6 Investments 7 Land 328,170.00 0.00 8 Equipment 552,300.00 706,070.00 (147,010.00) 9 Accumulated depreciation-equipment (165,580.00) $2,363,960.00 $2,057,080.00 10 Total assets Liabilities and Stockholders' Equity 11 1. $424,300.00 $404,860.00 12 Accounts payable (merchandise creditors) 13 Accrued expenses payable (operating expenses) 41,850.00...
Instructions The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets 3 Cash $626,640.00 $585,760.00 Accounts receivable (net) 226,900.00 208,390.00 Inventories 641,350.00 616,130.00 Investments 0.00 239,300.00 Land 328,730.00 0.00 Equipment 705,940.00 Accumulated depreciation-equipment (166,970.00) 553,530.00 (148,000.00) $2,055,110.00 Total assets $2,362,590.00 Liabilities and Stockholders' Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses) 42,020.00 52,750.00 Dividends payable 23,580.00 19,500.00 Common stock, $4...
Statement of Cash Flows—Indirect Method The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $244,600 $230,160 Accounts receivable (net) 88,610 82,660 Inventories 250,140 244,740 Investments 0 94,820 Land 128,300 0 Equipment 275,980 216,380 Accumulated depreciation—equipment (64,610) (58,350) Total assets $923,020 $810,410 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $167,070 $159,650 Accrued expenses payable (operating expenses) 16,610 21,070 Dividends payable 9,230 7,290 Common stock,...